cefuroxime and baci-im
cefuroxime has been researched along with baci-im in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Collins, B; Cotter, PD; Curtis, N; Hill, C; Ross, RP | 1 |
| Collins, B; Cotter, PD; Hill, C; Joyce, S; Ross, RP | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Reviews
1 review(s) available for cefuroxime and baci-im
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other Studies
2 other study(ies) available for cefuroxime and baci-im
| Article | Year |
|---|---|
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacitracin; Bacterial Proteins; beta-Lactam Resistance; Listeria monocytogenes; Nisin | 2010 |
TelA contributes to the innate resistance of Listeria monocytogenes to nisin and other cell wall-acting antibiotics.
Topics: Anti-Bacterial Agents; Bacitracin; Bacterial Proteins; Bacteriocins; Cefuroxime; Cell Wall; Drug Resistance, Multiple, Bacterial; Listeria monocytogenes; Nisin; Peptides; Tellurium | 2010 |